Pyxis Oncology Names Thomas Civik CEO and Board Chair
Pyxis Oncology appointed Thomas Civik permanent Chief Executive Officer and Chairman of the Board effective September 4, 2026. Civik had served as interim CEO since February 2 and has been a director since 2021….
